Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
-8.36x3.9x-0.22x3.65x-6.74x-6.33x-.--% 2.08B
16.06x1.87x-2.33x3.47x9.38x10.26x0.63% 63.09B
27.6x4.16x2.06x5.6x16.38x20.41x0.57% 55.61B
34.26x6.91x0.66x11.6x21.89x25.91x-.--% 41.64B
-52.41x2.39x0.42x3.11x9.18x10.71x3.5% 38.98B
32.61x1.61x-1.1x3.5x10.75x12.51x-.--% 29.82B
-6.91x4.07x-0.36x9.65x-5.88x-5.58x-.--% 23.71B
16.02x3.19x3.4x2.93x9.07x8.95x-.--% 21.48B
47.92x4.85x0.25x5.23x36.25x33.49x-.--% 16.87B
25.96x3.67x0.02x5.39x14.51x20.05x-.--% 16.74B
-32.03x-5.56x0.75x14.93x-45.4x-47.19x-.--% 13.65B
68.61x27.98x0.65x41.79x59.1x60.95x0.14% 13.04B
-120.41x12570.44x2.59x12.28x-108.81x-119.56x-.--% 12.21B
16.28x - 0.17x3.49x12.78x15.32x-.--% 11.08B
46.68x - 3.67x - - - -.--% 10.61B
11.95x1.04x0.41x1.81x7.32x9.81x2.81% 6.27B
-47.75x - -0.86x - - - - 6.02B
62.04x4.39x-0.8x - - - - 5.87B
12.71x1.17x-0.19x2.13x5.58x6.67x1.76% 5.12B
-104.29x - 6.91x - - - -.--% 5.11B
Average 2.33x 789.75x 0.81x 8.16x 2.83x 3.52x 0.52% 19.95B
Weighted average by Cap. 9.16x 423.12x 0.41x 7.21x 8.15x 9.57x 0.61%
Biopharmaceuticals